Happy new year holders ans observers. This should be. a great...

Happy new year holders ans observers. This should be. a great year for BCT and the year when the market finally notices them.

A few things Im looking forward to in the next few months:

4Q18 update:
- frankly the only thing that matters is how deliveries increased in Dec or Jan. As mngt highlighted in every ann, they would be building inventories in October, Nov to meet demand from Labcon from Dec/Jan onwards.
- i would like to see Dec sales in the $80-100m range.
- in my guesstimates, 1H sales will be in $300-350k, with 2H going into $1.15m as deliveries rise quickly (monthly rates of $150k was o $200k to $250k by May/June).. meeting the contractual orders of $1.5m for FY19
- again, what matters is the monthly rates in Dec, Jan and how it rises from Feb onwards.

Labcon launch:
- thats expected later this quarter.

Progress on IvF:
- following Genea's one year on sale, the new Chinese buyers will be able to refocus the business ans advance their project with BCT.

More agreements:
- hard to pin point when it will happen but even small contracts would be nice to show more diversity of customers

R&D tax refund:
- co should get a $1m back in cash sometime this quarter.

there is a lot to look forward to and - with some more market interaction by the company - im expecting to see
the stock in the list of ASX best performing stocks for 2019. that's long overdue!